公开(公告)号：US20200023123A1

公开(公告)日：2020-01-23

申请号：US16515749

申请日：2019-07-18

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Ian MCLAUGHLIN ,  Daniel ALLIS ,  David NAZZARO

IPC: A61M5/145 ,  A61M5/142 ,  A61M5/158 ,  A61M5/162 ,  A61M5/168

Abstract: Disclosed are examples for a system for drug delivery and components thereof. The system may include an on-body pump device and a secondary unit. The on-body pump device may include a reservoir and a fluid pathway. The reservoir may be configured to hold a liquid drug. The secondary unit may be removably coupled to the on-body pump device. The secondary unit may be configured to receive a prefilled cartridge containing a liquid drug, expel the liquid drug from the prefilled cartridge, and deliver the liquid drug to the reservoir of the on-body pump device via the fluid pathway. Examples of variations to the secondary unit are also disclosed.

公开(公告)号：US20190336683A1

公开(公告)日：2019-11-07

申请号：US16402753

申请日：2019-05-03

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Joon Bok LEE ,  Trang LY ,  Yibin ZHENG ,  Thomas Arnold PEYSER ,  Jennifer Lena SCHNEIDER

IPC: A61M5/172 ,  A61M5/142 ,  A61M5/145 ,  A61B5/145

Abstract: Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.

公开(公告)号：US20190336682A1

公开(公告)日：2019-11-07

申请号：US15969295

申请日：2018-05-02

Applicant: Insulet Corporation

Inventor： David COLLERAN ,  David NAZZARO ,  Jason O'CONNOR ,  Aiman Albert ABDEL-MALEK

IPC: A61M5/172 ,  A61M5/142 ,  G16H20/10 ,  G06K7/00 ,  G06K7/14 ,  G06K7/10

Abstract: A drug delivery system is provided. The drug delivery system can include a drug delivery device configured to store and deliver a drug to a user and a drug delivery management device for managing operation of the drug delivery device. The drug delivery management device can determine information relating to the drug that is to be provided to the user. The information relating to the drug can be provided by an indicator coupled to a container configured to store the drug. The drug delivery management device can determine a software program for controlling operation of the drug delivery management device based on the determined information relating to the drug. Other embodiments are disclosed and described.